These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30577764)

  • 21. Adverse events from cough and cold medications after a market withdrawal of products labeled for infants.
    Shehab N; Schaefer MK; Kegler SR; Budnitz DS
    Pediatrics; 2010 Dec; 126(6):1100-7. PubMed ID: 21098150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected infant deaths associated with use of cough and cold medications.
    Rimsza ME; Newberry S
    Pediatrics; 2008 Aug; 122(2):e318-22. PubMed ID: 18676517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
    Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
    Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More discussion of over the counter cough and cold preparations.
    Clark RF; Ly B; Schneir A; Cantrell FL; Tomaszewski C; Tanen DA
    Ann Emerg Med; 2009 Aug; 54(2):309-10. PubMed ID: 19616731
    [No Abstract]   [Full Text] [Related]  

  • 26. The impact of pediatric labeling changes on prescribing patterns of cough and cold medications.
    Mazer-Amirshahi M; Rasooly I; Brooks G; Pines J; May L; van den Anker J
    J Pediatr; 2014 Nov; 165(5):1024-8.e1. PubMed ID: 25195159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
    Dorr DA; Burdon R; West DP; Lagman J; Georgopoulos C; Belknap SM; McKoy JM; Djulbegovic B; Edwards BJ; Weitzman SA; Boyle S; Tallman MS; Talpaz M; Sartor O; Bennett CL
    Clin Cancer Res; 2009 Jun; 15(11):3850-5. PubMed ID: 19458059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events associated with opioid-containing cough and cold medications in children.
    Paul IM; Reynolds KM; Green JL
    Clin Toxicol (Phila); 2018 Nov; 56(11):1162-1164. PubMed ID: 29631464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cough and cold medication withdrawal and warning on ingestions by young children reported to Texas poison centers.
    Forrester MB
    Pediatr Emerg Care; 2012 Jun; 28(6):510-3. PubMed ID: 22653460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Woo EJ; Moro PL; Cano M; Jankosky C
    Vaccine; 2017 Oct; 35(42):5618-5621. PubMed ID: 28886946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.
    Bergvall T; Norén GN; Lindquist M
    Drug Saf; 2014 Jan; 37(1):65-77. PubMed ID: 24343765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report.
    Gummin DD; Mowry JB; Spyker DA; Brooks DE; Fraser MO; Banner W
    Clin Toxicol (Phila); 2017 Dec; 55(10):1072-1252. PubMed ID: 29185815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric Fatalities Associated With Over-the-Counter Cough and Cold Medications.
    Halmo LS; Wang GS; Reynolds KM; Delva-Clark H; Rapp-Olsson M; Banner W; Bond GR; Kauffman RE; Palmer RB; Paul IM; Green JL; Dart RC
    Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34607934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. US emergency department visits for acute harms from over-the-counter cough and cold medications, 2017-2019.
    Mital R; Lovegrove MC; Moro RN; Geller AI; Weidle NJ; Lind JN; Budnitz DS
    Pharmacoepidemiol Drug Saf; 2022 Feb; 31(2):225-234. PubMed ID: 34757641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Interoperable Computable Phenotype Algorithms for Adverse Events of Special Interest to Be Used for Biologics Safety Surveillance: Validation Study.
    Holdefer AA; Pizarro J; Saunders-Hastings P; Beers J; Sang A; Hettinger AZ; Blumenthal J; Martinez E; Jones LD; Deady M; Ezzeldin H; Anderson SA
    JMIR Public Health Surveill; 2024 Jul; 10():e49811. PubMed ID: 39008361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report.
    Mowry JB; Spyker DA; Brooks DE; Zimmerman A; Schauben JL
    Clin Toxicol (Phila); 2016 Dec; 54(10):924-1109. PubMed ID: 28004588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of over-the-counter cough and cold medicines for use in children.
    Vassilev ZP; Kabadi S; Villa R
    Expert Opin Drug Saf; 2010 Mar; 9(2):233-42. PubMed ID: 20001764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A primer of drug safety surveillance: an industry perspective. Part I: Information flow, new drug development, and federal regulations.
    Allan MC
    J Pharm Technol; 1992; 8(4):162-7. PubMed ID: 10121011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.